MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion(R) Processed Human Amniotic Membrane Allografts In Vitro
(NASDAQ:MDXG), MARIETTA, Ga., Dec. 19, 2025 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the latest addition to its industry-leading body of scientific and clinical evidence supporting the use of its dehydrated human amnion chorion membrane (DHACM) and lyophilized human amnion chorion membrane (LHACM) products, in the Journal of […]